Brigitte Mlineritsch
Salzburg, 5020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 17, 2020
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Journal: Breast care (Basel, Switzerland)
Published: June 03, 2020
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 15, 2018
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Journal: Breast cancer research : BCR
Published: August 27, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Journal: BMC cancer
Published: September 12, 2017
Adjuvant medical treatment for breast cancer in elderly and old women.
Journal: Memo
Published: December 15, 2015
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Journal: International journal of molecular sciences
Published: November 30, 2015
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Journal: The pharmacogenomics journal
Published: September 08, 2015
Last Updated: 09/26/2026